Physician

Ambreen Malik, MD

According to 2025 Medicare claims, Ambreen Malik, MD (NPI: 1598250771) practices infectious disease in the Lansing-East Lansing, MI market, with the plurality of this provider's patient population coming from Ingham, MI. This provider's primary affiliated billing organization is EDWARD W. SPARROW HOSPITAL ASSOCIATION (NPI: 1508438995; TIN: 381360584) and primary practice location at 48912-1811. Malik is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Malik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 77 traditional Medicare patients, billed 177 HCPCS/CPT codes, and received $13,351 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 168 prescription claims across 40 beneficiaries totaling $41,351 in drug costs, led by Daptomycin (Daptomycin). Open Payments data shows 2 records totaling $157. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $474 to $41,351. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$6.7K$13K2024 Medicare payment: $13,351 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202477177$13,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$133K$266K2018 Drug cost: $474 (USD; Tot_Drug_Cst)2019 Drug cost: $1,152 (USD; Tot_Drug_Cst)2020 Drug cost: $1,427 (USD; Tot_Drug_Cst)2021 Drug cost: $27,730 (USD; Tot_Drug_Cst)2022 Drug cost: $143,197 (USD; Tot_Drug_Cst)2023 Drug cost: $265,908 (USD; Tot_Drug_Cst)2024 Drug cost: $41,351 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181633$474
20192036$1,152
2020N/R36$1,427
20211958$27,730
20222892$143,197
202326109$265,908
202440168$41,351

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1516$125
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes3840$100
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1519$86
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes4070$59

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DaptomycinDaptomycin14100$6,871
CeftriaxoneCeftriaxone Sodium34224$2,299
Cefazolin SodiumCefazolin Sodium16110$650

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$157Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ambreen Malik, MD?

Tedicare shows public-source Medicare data for Ambreen Malik, MD (NPI 1598250771), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ambreen Malik, MD have ACO affiliation data?

Ambreen Malik, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Ambreen Malik, MD?

Ambreen Malik, MD is linked to EDWARD W. SPARROW HOSPITAL ASSOCIATION (billing NPI 1508438995) in the available physician profile data.

Does Ambreen Malik, MD have Open Payments data?

Ambreen Malik, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.